BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7795280)

  • 1. Platin salts-induced hemolytic anemia: cisplatin- and the first case of carboplatin-induced hemolysis.
    Maloisel F; Kurtz JE; Andres E; Gorodetsky C; Dufour P; Oberling F
    Anticancer Drugs; 1995 Apr; 6(2):324-6. PubMed ID: 7795280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisplatin-induced anemia: a potential interference with iron metabolism at erythroid progenitors level.
    Dufour P; Bergerat JP; Eber M; Renaud P; Karcher V; Giron C; Leroy MJ; Oberling F
    Anticancer Drugs; 1990 Oct; 1(1):49-54. PubMed ID: 2131037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME; Laber DA
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced hemolysis.
    Getaz EP; Beckley S; Fitzpatrick J; Dozier A
    N Engl J Med; 1980 Feb; 302(6):334-5. PubMed ID: 7188625
    [No Abstract]   [Full Text] [Related]  

  • 5. Cis-platin induced anaemia.
    Kumar L; Dua H
    N Z Med J; 1987 Feb; 100(817):81. PubMed ID: 3469552
    [No Abstract]   [Full Text] [Related]  

  • 6. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells.
    Zeger G; Smith L; McQuiston D; Goldfinger D
    Transfusion; 1988; 28(5):493-5. PubMed ID: 3420679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolytic anemia associated with antineoplastic agents.
    Doll DC; Weiss RB
    Cancer Treat Rep; 1985; 69(7-8):777-82. PubMed ID: 3160460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed response of the red blood system (erythron) to carboplatin administration during pregnancy].
    Karpova GV; Borovskaia TG; Timina EA; Pakhomova AV
    Eksp Klin Farmakol; 2004; 67(2):38-40. PubMed ID: 15188759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic anemia caused by cisdiamino-dichloroplatinum. Lack of cross-reaction with carboplatin].
    Weber JC; Couppie P; Maloisel F; Dufour P; Krause C; Oberling F
    Presse Med; 1990 Mar; 19(11):526-7. PubMed ID: 2138756
    [No Abstract]   [Full Text] [Related]  

  • 10. Carboplatin-induced immune hemolytic anemia.
    Marani TM; Trich MB; Armstrong KS; Ness PM; Smith J; Minniti C; Sandler SG
    Transfusion; 1996; 36(11-12):1016-8. PubMed ID: 8937414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies to ameliorate toxicity of carboplatin.
    ten Bokkel Huinink WW; Dercksen MW; van Tinteren H
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):27-33; quiz 34, 58. PubMed ID: 8202718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-mediated hemolytic anemia induced by penicillin in horses.
    Blue JT; Dinsmore RP; Anderson KL
    Cornell Vet; 1987 Jul; 77(3):263-76. PubMed ID: 3677710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea-induced hemolytic anemia in a patient with essential thrombocythemia.
    Jabr FI; Shamseddine A; Taher A
    Am J Hematol; 2004 Dec; 77(4):374-6. PubMed ID: 15558807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic anemia.
    Dhaliwal G; Cornett PA; Tierney LM
    Am Fam Physician; 2004 Jun; 69(11):2599-606. PubMed ID: 15202694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review.
    Ainsworth CD; Crowther MA; Treleaven D; Evanovitch D; Webert KE; Blajchman MA
    Transfus Med Rev; 2009 Apr; 23(2):155-9. PubMed ID: 19304116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A severe case of cefoxitin-induced immune hemolytic anemia.
    Leaf DE; Langer NB; Markowski M; Garratty G; Diuguid DL
    Acta Haematol; 2010; 124(4):197-9. PubMed ID: 21042010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of hemolysis induced by lansoprazole].
    Suzuki T; Hayashi T; Nonaka Y; Hirano M; Nomura T; Miyazawa I; Ishikawa F; Kakiuchi T
    Rinsho Ketsueki; 1996 Dec; 37(12):1389-94. PubMed ID: 8997127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
    Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
    Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption.
    Arndt P; Garratty G; Isaak E; Bolger M; Lu Q
    Transfusion; 2009 Apr; 49(4):711-8. PubMed ID: 19192254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced anemia.
    Nguyen BV; Jaffe N; Lichtiger B
    Cancer Treat Rep; 1981; 65(11-12):1121. PubMed ID: 6945912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.